Skip to main content
Clinical Trials/NCT07257666
NCT07257666
Completed
Not Applicable

The Effect of Platelet-rich Fibrin on the Regeneration of Patellar Ligament Defects and the Functional Recovery of Patients After Anterior Cruciate Ligament Reconstruction of the Knee

University of Belgrade1 site in 1 country53 target enrollmentStarted: January 7, 2022Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
53
Locations
1
Primary Endpoint
Proportion of participants without anterior knee sensory deficit at the donor site

Overview

Brief Summary

Pilot, single-center, non-randomized, parallel-group clinical study designed to assess whether intraoperative application of autologous platelet-rich fibrin (PRF) at the bone-patellar tendon-bone (BPTB) donor site reduces postoperative anterior knee sensory deficit after anterior cruciate ligament (ACL) reconstruction in competitively active male athletes. Planned enrollment is 53 participants allocated to a PRF cohort or a standard-care cohort. The primary outcome is the proportion of participants without anterior knee sensory deficit at 12 months post-surgery.

Detailed Description

Background: Sensory deficit around the BPTB donor site is a recognized complication after ACL reconstruction and may affect patient satisfaction and functional recovery. PRF is an autologous bioregenerative product with potential to support soft-tissue healing.

Objective

To determine whether PRF application at the donor site reduces anterior knee sensory deficit compared with standard surgical care.

Design and Participants: Single-center, prospective, pilot, non-randomized study with two parallel cohorts (PRF vs standard care). Competitively active male athletes meeting prespecified eligibility criteria are followed at 4, 8, and 12 months post-surgery. Recruitment window: January 2022 to January 2023.

Interventions: In the PRF cohort, PRF is prepared intraoperatively and applied to the donor site per manufacturer protocol; the comparator cohort receives standard closure without PRF.

Assessments:

Primary outcome: Proportion of participants without anterior knee sensory deficit at 12 months. Sensory testing is performed over a predefined 9-point area lateral to the surgical scar (eyes closed; contralateral knee used as reference if uncertain).

Secondary outcomes: Patient-reported knee function instruments (International Knee Documentation Committee [IKDC] Subjective Knee Form and Lysholm Knee Scoring Scale), each reported as total score (0-100; higher scores indicate better function) at 4, 8, and 12 months; optional MRI-based assessments of the donor site per protocol; safety monitoring of adverse events.

Analysis (planned): Group comparisons using appropriate categorical and non-parametric methods with prespecified approaches to handle multiplicity.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age 18-40 years
  • Isolated anterior cruciate ligament rupture confirmed by MRI and clinical examination
  • Planned ACL reconstruction with BPTB autograft
  • Written informed consent provided

Exclusion Criteria

  • Previous knee surgery on the affected knee
  • Associated ligament injuries requiring additional reconstruction
  • Significant cartilage damage (Outerbridge grade III-IV beyond donor site changes)
  • Systemic disease affecting wound healing (e.g., diabetes mellitus, autoimmune disease)
  • Active infection
  • Refusal or inability to provide informed consent

Arms & Interventions

PRF Group

Patients undergoing ACL reconstruction with a bone-patellar tendon-bone (BPTB) autograft, with platelet-rich fibrin (PRF) applied at the donor site (n=24)

Intervention: Platelet-rich fibrin (PRF) (Biological)

Control Group

Patients undergoing ACL reconstruction with a BPTB autograft, treated with standard closure without PRF (n=29)

Intervention: Standard Closure (Control) (Procedure)

Outcomes

Primary Outcomes

Proportion of participants without anterior knee sensory deficit at the donor site

Time Frame: 12 months post-surgery

Sensory function assessed over a predefined 9-point area lateral to the surgical scar; deficit coded as 1 if \>3 points are reported as "no or altered touch," otherwise 0. Assessment performed with eyes closed; contralateral knee used for reference if uncertain. Measure Type \& Units: Percentage of participants (%)

Secondary Outcomes

  • International Knee Documentation Committee (IKDC) Subjective Knee Form score (0-100; higher scores indicate better function)(Baseline, 4, 8, and 12 months post-surgery)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Darko Milovanovic

Principal Investigator, University Clinical Center of Serbia, Docent, Faculty of Medicine, University of Belgrade

University of Belgrade

Study Sites (1)

Loading locations...

Similar Trials